Download PDF
J Pediatr Intensive Care 2016; 05(01): 037-040
DOI: 10.1055/s-0035-1568151
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Baclofen Toxicity Responsive to Hemodialysis in a Pediatric Patient with Acute Kidney Injury

Samantha W. Gee
1   Section of Pediatric Critical Care, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, United States
,
Shad Outsen
1   Section of Pediatric Critical Care, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, United States
,
Brian Becknell
2   Section of Pediatric Nephrology, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, United States
,
Andrew L. Schwaderer
2   Section of Pediatric Nephrology, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, United States
› Author Affiliations
Further Information

Publication History

11 December 2014

07 May 2015

Publication Date:
21 November 2015 (online)

    Permissions and Reprints

Abstract

Background Baclofen (para-chlorophenyl-gamma-aminobutyric acid) is widely used for its therapeutic effect of providing muscle relaxation from the persistent muscle spasms and posturing often related to spinal and central nervous system injuries. However, baclofen is also a potent neuronal depressant which is most evident in cases of toxicity. In severe toxicity, respiratory failure and obtundation may occur.

Case-diagnosis/treatment We present the case of a neurologically devastated 16-year-old on chronic baclofen therapy for bilateral spastic cerebral palsy (Gross Motor Function Classification System level V) who presented with fever, leukocytosis, and hypotension. Initial management with fluid resuscitation and antimicrobials for presumed infection did initially improve the patient's mental status; however, he subsequently became comatose later during the same hospitalization. Comprehensive diagnostic studies and infectious work-up did not reveal an etiology. Upon further examination of history, acute kidney injury from chronic nonsteroidal use and complicated by vancomycin toxicity was suspected to cause acute baclofen toxicity. The patient underwent a single run of hemodialysis with resultant neurologic improvement and later laboratory-confirmed toxic baclofen levels.

Conclusion Clinicians should consider possible acute baclofen toxicity in patients with impaired renal function who present with neurologic depression. Respiratory failure and mechanical ventilation, with its associated intensive care costs and complications, may be avoided with prompt treatment using hemodialysis.

Keywords

baclofen - hemodialysis - acute kidney injury - toxicity
 

  • References

  • 1 Perry HE, Wright RO, Shannon MW, Woolf AD. Baclofen overdose: drug experimentation in a group of adolescents. Pediatrics 1998; 101 (6) 1045-1048
    CrossrefPubMedGoogle Scholar
  • 2 Ghose K, Holmes KM, Matthewson K. Complications of baclofen overdosage. Postgrad Med J 1980; 56 (662) 865-867
    CrossrefPubMedGoogle Scholar
  • 3 He Y, Brunstrom-Hernandez JE, Thio LL , et al. Population pharmacokinetics of oral baclofen in pediatric patients with cerebral palsy. J Pediatr 2014; 164 (5) 1181-1188.e8
    CrossrefPubMedGoogle Scholar
  • 4 Wuis EW, Dirks MJ, Termond EF, Vree TB, Van der Kleijn E. Plasma and urinary excretion kinetics of oral baclofen in healthy subjects. Eur J Clin Pharmacol 1989; 37 (2) 181-184
    CrossrefPubMedGoogle Scholar
  • 5 Chen KS, Bullard MJ, Chien YY, Lee SY. Baclofen toxicity in patients with severely impaired renal function. Ann Pharmacother 1997; 31 (11) 1315-1320
    PubMedGoogle Scholar
  • 6 Wu VC, Lin SL, Lin SM, Fang CC. Treatment of baclofen overdose by haemodialysis: a pharmacokinetic study. Nephrol Dial Transplant 2005; 20 (2) 441-443
    CrossrefPubMedGoogle Scholar
  • 7 Dias LS, Vivek G, Manthappa M, Acharya RV. Role of hemodialysis in baclofen overdose with normal renal function. Indian J Pharmacol 2011; 43 (6) 722-723
    PubMedGoogle Scholar
  • 8 Hsieh MJ, Chen SC, Weng TI, Fang CC, Tsai TJ. Treating baclofen overdose by hemodialysis. Am J Emerg Med 2012; 30 (8) 1654.e5-1654.e7
    PubMedGoogle Scholar
  • 9 Young RR, Delwaide PJ. Drug therapy: spasticity (second of two parts). N Engl J Med 1981; 304 (2) 96-99
    CrossrefPubMedGoogle Scholar
  • 10 Vlavonou R, Perreault MM, Barrière O , et al. Pharmacokinetic characterization of baclofen in patients with chronic kidney disease: dose adjustment recommendations. J Clin Pharmacol 2014; 54 (5) 584-592
    CrossrefPubMedGoogle Scholar
  • 11 Byrnes SM, Watson GW, Hardy PA. Flumazenil: an unreliable antagonist in baclofen overdose. Anaesthesia 1996; 51 (5) 481-482
    CrossrefPubMedGoogle Scholar
  • 12 Saissy JM, Vitris M, Demazière J, Seck M, Marcoux L, Gaye M. Flumazenil counteracts intrathecal baclofen-induced central nervous system depression in tetanus. Anesthesiology 1992; 76 (6) 1051-1053
    CrossrefPubMedGoogle Scholar
  • 13 Chapple D, Johnson D, Connors R. Baclofen overdose in two siblings. Pediatr Emerg Care 2001; 17 (2) 110-112
    CrossrefPubMedGoogle Scholar
  • 14 Wiersma HE, van Boxtel CJ, Butter JJ, van Aalderen WM, Omari T, Benninga MA. Pharmacokinetics of a single oral dose of baclofen in pediatric patients with gastroesophageal reflux disease. Ther Drug Monit 2003; 25 (1) 93-98
    CrossrefPubMedGoogle Scholar
  • 15 Anderson P, Nohér H, Swahn CG. Pharmacokinetics in baclofen overdose. J Toxicol Clin Toxicol 1984; 22 (1) 11-20
    CrossrefPubMedGoogle Scholar